Regulation of turnover of tumor suppressor p53 and cell growth by E6-AP, a ubiquitin protein ligase mutated in Angelman mental retardation syndrome

Cellular and Molecular Life Sciences

Volumn 65, Issue 4, 2008, Pages 656-666

  Mishra, A ^a   Jana, N R ^a  

^a NATIONAL BRAIN RESEARCH CENTRE   (India)

Author keywords

Angelman syndrome; Apoptosis; Cell growth; E6 AP; p53; Transcription

Indexed keywords

PROTEIN E6; PROTEIN P53; UBIQUITIN PROTEIN LIGASE;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL GROWTH; CONTROLLED STUDY; HAPPY PUPPET SYNDROME; IN VITRO STUDY; MENTAL RETARDATION MALFORMATION SYNDROME; NERVE CELL; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN METABOLISM; SEQUENCE HOMOLOGY; UBIQUITINATION;

ANGELMAN SYNDROME; BASE SEQUENCE; CELL DIVISION; CELL LINE, TUMOR; DNA PRIMERS; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; KINETICS; MENTAL RETARDATION; MOLECULAR SEQUENCE DATA; NEURONS; PLASMIDS; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN-PROTEIN LIGASES;

HUMAN PAPILLOMAVIRUS;

EID: 39749139563     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-007-7476-1     Document Type: Article

References (47)

1. Williams, C. A., Zori, R. T., Hendrickson, J., Stalker, H., Marum, T., Whidden, E. and Driscoll, D. J. (1995) Angelman syndrome. Curr. Probl. Pediatr. 25, 216-231.
2. Clayton-Smith, J. and Laan, L. (2003) Angelman syndrome: A review of the clinical and genetic aspects. J. Med. Genet. 40, 87-95.
3. Laan, L. A., Haeringen, A. and Brouwer, O. F. (1999) Angelman syndrome: A review of clinical and genetic aspects. Clin. Neurol. Neurosurg. 101, 161-170.
4. Jiang, Y., Lev-Lehman, E., Bressler, J., Tsai, T. F. and Beaudet, A. L. (1999) Genetics of Angelman syndrome. Am. J. Hum. Genet. 65, 1-6.
5. Robinson, W. P., Christian, S. L., Kuchinka, B. D., Penaherrera, M. S., Das, S., Schuffenhauer, S., Malcolm, S., Schinzel, A. A., Hassold, T. J. and Ledbetter, D. H. (2000) Somatic segregation errors predominantly contribute to the gain or loss of a paternal chromosome leading to uniparental disomy for chromosome 15. Clin. Genet. 57, 349-358.
6. Albrecht, U., Sutcliffe, J. S., Cattanach, B. M., Beechey, C. V., Armstrong, D., Eichele, G. and Beaudet, A. L. (1997) Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons. Nat. Genet. 17, 75-78.
7. Ohta, T., Buiting, K., Kokkonen, H., McCandless, S., Heeger, S., Leisti, H., Driscoll, D. J., Cassidy, S. B., Horsthemke, B. and Nicholls, R. D. (1999) Molecular mechanism of Angelman syndrome in two large families involves an imprinting mutation. Am. J. Hum. Genet. 64, 385-396.
8. Matsuura, T., Sutcliffe, J. S., Fang, P., Galjaard, R. J., Jiang, Y. H., Benton, C. S., Rommens, J. M. and Beaudet, A. L. (1997) De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome. Nat. Genet. 15, 74-77.
9. Fang, P., Lev-Lehman, E., Tsai, T. F., Matsuura, T., Benton, C. S., Sutcliffe, J. S., Christian, S. L., Kubota, T., Halley, D. J., Meijers-Heijboer, H., Langlois, S., Graham, J. M. Beuten, J., Willems, P. J. Ledbeter, D. H. and Beaudet, A. L. (1999) The spectrum of mutations in UBE3A causing Angelman syndrome. Hum. Mol. Genet. 8, 129-135.
10. Kishino, T., Lalande, M. and Wagstaff, J. (1997) UBE3A/E6-AP mutations cause Angelman syndrome. Nat. Genet. 15, 70-73.
11. Malzac, P., Webber, H., Moncla, A., Graham, J. M., Kukolich, M., Williams, C., Pagon, R. A., Ramsdell, L. A., Kishino, T. and Wagstaff, J. (1998) Mutation analysis of UBE3A in Angelman syndrome patients. Am. J. Hum. Genet. 62, 1353-1360.
12. Huibregtse, J. M., Scheffner, M. and Howley, P. M. (1993) Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Mol. Cell. Biol. 13, 775-784.
13. Scheffner, M., Huibregtse, J. M., Vierstra, R. D. and Howley, P. M. (1993) The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75, 495-505.
14. Glickman, M. H. and Ciechanover, A. (2002) The ubiquitin-proteasome proteolytic pathway: Destruction for the sake of construction. Physiol. Rev. 82, 373-428.
15. Huibregtse, J. M., Scheffner, M., Beaudenon, S. and Howley, P. M. (1995) A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase. Proc. Natl. Acad. Sci. USA 92, 2563-2567.
16. Scheffner, M., Nuber, U. and Huibregtse, J. M. (1995) Protein ubiquitination involving an E1-E2-E3 enzyme ubiquitin thioester cascade. Nature 373, 81-83.
17. Cooper, E. M., Hudson, A. W., Amos, J., Wagstaff, J. and Howley, P. M. (2004) Biochemical analysis of Angelman syndrome-associated mutations in the E3 ubiquitin ligase E6-associated protein. J. Biol. Chem. 279, 41208-41217.
18. Kumar, S., Talis, A. L. and Howley, P. M. (1999) Identification of HHR23A as a substrate for E6-associated protein-mediated ubiquitination. J. Biol. Chem. 274, 18785-18792.
19. Kuhne, C. and Banks, L. (1998) E3-ubiquitin ligase/E6-AP links multicopy maintenance protein 7 to the ubiquitination pathway by a novel motif, the L2G box. J. Biol. Chem. 273, 34302-3439.
20. Oda, H., Kumar, S. and Howley, P. M. (1999) Regulation of the Src family tyrosine kinase Blk through E6AP-mediated ubiquitination. Proc. Natl. Acad. Sci. USA 96, 9557-9562.
21. Reiter, L. T., Seagroves, T. N., Bowers, M. and Bier, E. (2006) Expression of the Rho-GEF Pbl/ECT2 is regulated by the UBE3AE3 ubiquitin ligase. Hum. Mol. Genet. 15, 2825-2835.
22. Nuber, U., Schwarz, S. E. and Scheffner, M. (1998) The ubiquitin-protein ligase E6-associated protein (E6-AP) serves as its own substrate. Eur. J. Biochem. 254, 643-649.
23. Nawaz, Z., Lonard, D. M., Smith, C. L., Lev-Lehman, E., Tsai, S. Y., Tsai, M. J. and O'Malley, B. W. (1999) The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily. Mol. Cell. Biol. 19, 1182-1189.
24. Beer-Romero, P., Glass, S. and Rolfe, M. (1997) Antisense targeting of E6AP elevates p53 in HPV-infected cells but not in normal cells. Oncogene 14, 595-602.
25. Daniels, P. R., Sanders, C. M. and Maitland, N. J. (1998) Characterization of the interactions of human papillomavirus type 16 E6 with p53 and E6-associated protein in insect and human cells. J. Gen. Virol. 79, 489-499.
26. Talis, A. L., Huibregtse, J. M. and Howley, P. M. (1998) The role of E6AP in the regulation of p53 protein levels in human papillomavirus (HPV)-positive and HPV-negative cells. J. Biol. Chem. 273, 6439-6445.
27. Jiang, Y. H., Armstrong, D., Albrecht, U., Atkins, C. M., Noebels, J. L., Eichele, G., Sweatt, J. D. and Beaudet, A. L. (1998) Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron 21, 799-811.
28. Khan, O. Y., Fu, G., Ismail, A., Srinivasan, S., Cao, X., Tu, Y., Lu, S. and Nawaz, Z. (2006) Multifunction steroid receptor coactivator, E6-associated protein, is involved in development of the prostate gland. Mol. Endocrinol. 20, 544-559.
29. Miura, K., Kishino, T., Li, E., Webber, H., Dikkes, P., Holmes, G. L. and Wagstaff, J. (2002) Neurobehavioral and electroencephalographic abnormalities in Ube3a maternal-deficient mice. Neurobiol. Dis. 9, 149-159.
30. Murata, S., Minami, Y., Minami, M., Chiba, T. and Tanaka, K. (2001) CHIP is a chaperone-dependent E3 ligase that ubiquitylates unfolded protein. EMBO Rep. 2, 1133-1138.
31. Jana, N. R., Dikshit, P., Goswami, A., Kotliarova, S., Murata, S., Tanaka, K. and Nukina, N. (2005) Co-chaperone CHIP associates with expanded polyglutamine protein and promotes their degradation by proteasomes. J. Biol. Chem. 280, 11635-11640.
32. Jana, N. R., Zemskov, E. A., Wang, G. and Nukina, N. (2001) Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release. Hum. Mol. Genet. 10, 1049-1059.
33. Hengstermann, A., Linares, L. K., Ciechanover, A., Whitaker, N. J. and Scheffner, M. (2001) Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells. Proc. Natl. Acad. Sci. USA 98, 1218-1223.
34. Wu, X., Bayle, J. H., Olson, D. and Levine, A. J. (1993) The p53-mdm-2 autoregulatory feedback loop. Genes Dev. 7, 1126-1132.
35. Brooks, C. L. and Gu, W. (2006) p53 ubiquitination: Mdm2 and beyond. Mol. Cell 21, 307-315.
36. Leng, R. P., Lin, Y., Ma, W., Wu, H., Lemmers, B., Chung, S., Parant, J. M., Lozano, G., Hakem, R. and Benchimol, S. (2003) Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation. Cell 112, 779-791.
37. Grossman, S. R., Deato, M. E., Brignone, C., Chan, H. M., Kung, A. L., Tagami, H., Nakatani, Y. and Livingston, D. M. (2003) Polyubiquitination of p53 by a ubiquitin ligase activity of p300. Science 300, 342-344.
38. Chen, D., Kon, N., Li, M., Zhang, W., Qin, J. and Gu, W. (2005) ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor. Cell 121, 1071-1083.
39. Dornan, D., Wertz, I., Shimizu, H., Arnott, D., Frantz, G. D., Dowd, P., O'Rourke, K., Koeppen, H. and Dixit, V. M. (2004) The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature 429, 86-92.
40. Esser, C., Scheffner, M. and Hohfeld, J. (2005) The chaperone-associated ubiquitin ligase CHIP is able to target p53 for proteasomal degradation. J. Biol. Chem. 280, 27443-27448.
41. Lipford, J. R. and Deshaies, R. J. (2003) Diverse roles for ubiquitin-dependent proteolysis in transcriptional activation. Nat. Cell. Biol. 5, 845-850.
42. Kodadek, T., Sikder, D. and Nalley, K. (2006) Keeping transcriptional activators under control. Cell 127, 261-264.
43. Smith, C. L., DeVera, D. G., Lamb, D. J., Nawaz, Z., Jiang, Y. H., Beaudet, A. L. and O'Malley, B. W. (2002) Genetic ablation of the steroid receptor coactivator-ubiquitin ligase, E6-AP, results in tissue-selective steroid hormone resistance and defects in reproduction. Mol. Cell. Biol. 22, 525-535.
44. Morrison, R. S. and Kinoshita, Y. (2000) The role of p53 in neuronal cell death. Cell Death Differ. 7, 868-879.
45. Vousden, K. H. and Lane, D. P. (2007) p53 in health and disease. Nat. Rev. Mol. Cell. Biol. 8, 275-283.
46. Jacobs, W. B., Kaplan, D. R. and Miller, F. D. (2006) The p53 family in nervous system development and disease. J. Neurochem. 97, 1571-1584.
47. Cummings, C. J., Reinstein, E., Sun, Y., Antalffy, B., Jiang, Y., Ciechanover, A., Orr, H. T., Beaudet, A. L. and Zoghbi, H. Y. (1999) Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice. Neuron 24, 879-892.